Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that triggers adaptive responses upon low oxygen conditions and plays a crucial role in cancer metabolism and therapy resistance. Tetrathiomolybdate (TM), a therapy option for copper overload disorder, has also been shown to be capable o...
Main Authors: | Kwang Kim, Kyu, Abelman, Sarah, Yano, Naohiro, Ribeiro, Jennifer R., Singh, Rakesh K., Tipping, Marla, Moore, Richard G. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606568/ |
Similar Items
-
Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
by: Kim, Kyu Kwang, et al.
Published: (2015) -
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
by: Kim, Kyu Kwang, et al.
Published: (2012) -
Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats
by: Omoto, Atsushi, et al.
Published: (2005) -
Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate
by: Calderon-Aparicio, Ali, et al.
Published: (2015) -
Xanthine Oxidase Mediates Hypoxia-Inducible Factor-2α Degradation by Intermittent Hypoxia
by: Nanduri, Jayasri, et al.
Published: (2013)